Clicky

Avita Medical Ltd(AVH)

Description: Avita Medical Limited is a medical technology company. The principal activities of the Company are the commercialization of its regenerative product. The Company has three segments: the Asia Pacific region; the Americas, including Canada, and the Europe, Middle East and Africa (EMEA) region. It develops and distributes regenerative products for the treatment of a range of wounds, scars and skin defects. Its collection and application technology provides treatment solutions derived from the regenerative properties of a patient's own skin. The Company's product, ReCell, is used in the treatment of a range of burns, plastic, reconstructive and cosmetic procedures. Its technology, Regenerative Epithelial Suspension (RES), is an autologous suspension composed of the cells and wound-healing factors necessary to regenerate natural skin. The Company also offers ReGenerCell, which is used for the treatment of wounds, and ReNovaCell, which is used for the treatment of pigmentation.


Keywords: Plastic Medical Technology Cars Wound Burns Scar Treatment Solutions Healing Regenerative Regenerative Products Application Technology Avita Medical

Home Page: www.avitamedical.com

AVH Technical Analysis

28159 Avenue Stanford
Valencia, CA 91355
United States
Phone: 661 367 9170


Officers

Name Title
Mr. James M. Corbett CEO, Pres & Exec. Director
Mr. Michael Bria Holder MBA Chief Financial Officer
Ms. Kathy M. McGee Chief Operating Officer
Mr. Andrew Quick Chief Technology Officer
Ms. Donna Shiroma Gen. Counsel & Sec.
Ms. Erin Liberto Chief Commercial Officer
Mr. David Fencil VP of Global Operations
Ms. Debbie Garner VP of Global Marketing

Exchange: AU

Country: AU

Currency: Australian Dollar (A$)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.8754
Price-to-Sales TTM: 10.5694
IPO Date:
Fiscal Year End: June
Full Time Employees: 116
Back to stocks